相关实验视频

Updated: Feb 22, 2026

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

作为对转移性前列腺癌 (mPC) 反应评估的新兴工具的PSMA-PET:革命和必要的演变

N Álvarez Mena¹, J Gómez Hidalgo², P Fierro Alanis³

¹Servicio de Medicina Nuclear, Hospital Clínico Universitario de Valladolid, Valladolid, Spain; Grupo de Trabajo de Oncología de la SEMNIM, Spain.

Revista espanola de medicina nuclear e imagen molecular

|February 20, 2026

概括

与传统方法相比,前列腺特异性膜抗原正子发射断层扫描 (PSMA-PET) 可以更好地评估转移性前列腺癌 (mPC) 的治疗反应. 像RECIP 1.0这样的新标准显示了与生存率的强烈相关性,改善了风险分层.

科学领域:

在瘤学瘤学.
核医学就是核医学.
放射学放射学是一门学科.

背景情况:

前列腺特异性膜抗原 (PSMA) 表达被转移性前列腺癌 (mPC) 的各种治疗方法调节,影响成像解释.
在mPC中评估治疗反应的常规标准,包括血清PSA水平,RECIST1.1和PCWG3,都有局限性.

研究的目的:

批判性地审查PSMA-PET的证据,以评估mPC中的治疗反应.
将PSMA-PET与传统的评估方法进行比较.
分析PSMA-PET在临床实践中的整合.

主要方法:

在mPC中对PSMA-PET的现有证据的审查.
通过不同的治疗方法 (ADT,ARPI,税,放射性连体疗法,-223,SBRT) 对PSMA表达调节的分析.
描述和比较PSMA-PET特定评估系统 (PPP,RECIP 1.0,EAU/EANM) 与RECIST和PCWG3.3的情况.

主要成果:

特定的PSMA-PET标准 (PPP,RECIP 1.0,EAU/EANM) 显示出比RECIST和PCWG3更高的预后价值,特别是在转移性割抵抗性前列腺癌 (mCRPC) 中.
RECIP 1.0与整体存活率和观察者间可重复性有着强烈的相关性,与PSA结合时增强了风险分层.
像PSMA-VOL和TLP这样的定量参数是响应监测和结果预测的关键生物标志物.

结论:

在mPC中,PSMA-PET是评估治疗反应的宝贵工具,提供了更好的预后准确性.
需要标准化报告和进一步的前性研究,以克服当前的局限性,如标准变化和多式联运一体化挑战.
优化PSMA-PET时间和报告对于有效的临床整合至关重要.

关键词:

在PSMA中响应的评估标准进步标准PET-PSMAMAPET-PSMAMAPET-PSMAMAPET-PSMAMAPET-PSMAMAPET-PSMAMAPET-PSMAPET-PSMAPET-PSMAPET-PSMAPET-PSMAPET-PSMAPET-PSMAPET-PSMAPET-PSMAPET-PSMAPET-PSMAP 这是一种PET-PSMA.PSMA PET 的进展标准这就是PSMA-PET.在RECIP 1.0中,我们将使用RECIP.在PSMA中响应评估标准.转移性转移性前列腺癌.转移性前列腺癌转移性前列腺癌治疗性反应疗法治疗反应的治疗反应.

更多相关视频

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

相关概念视频

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...